The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications. GLP-1 receptor agonist drugs carry serious side effects ranging from nausea and vomiting to pancreatitis, acute kidney injury, bowel obstruction, and medullary thyroid cancer, the Ministry of Health and Family Welfare warned on 1 April, 2026
For people in this BMI range, GLP-1 therapy sometimes serves as a bridge to other interventions or as an alternative to bariatric surgery
Diabetes 63 , 18291830 (2014)
These medications enable better glycemic control, greater weight loss, appetite regulation, and potential cardiovascular risk reduction by combining GLP-1 receptor agonists with amylin-based therapy, which is generating increasing clinical attention
a novel role of GLP-1 receptor agonists in cirrhotic cardiomyopathy
Memory Enhancement Improves cognitive function and supports brain health